Restricted accessLetterFirst published online 2017-04
Response to Tulchinsky and Avram re: “Long-Term Outcomes of Patients with Papillary Thyroid Cancer Undergoing Remnant Ablation with 30 Millicurie Radioiodine”
TulchinskyM, AvramAM. 2017. Re: “Long-term outcomes of patients with papillary thyroid cancer undergoing remnant ablation with 30 milliCurie radioiodine” by Mujammami et al. (Thyroid 2016;26:951–958): patient cohort definition makes no sense. Thyroid, 27:591.
2.
MujammamiM, HierMP, PayneRJ, RochonL, TamiliaM. 2016. Long-term outcomes of patients with papillary thyroid cancer undergoing remnant ablation with 30 milliCuries radioiodine. Thyroid, 26:951–958.
